News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Novartis
NEWS
JOBS
IN THE PRESS
NEWS
Job Trends
Fall From Grace: BioSpace Readers Sound Off On Novartis AG And Other Pharma Layoffs
July 18, 2014
·
3 min read
Job Trends
Novartis AG Layoffs Announced: More Cuts May Be Looming
July 14, 2014
·
4 min read
Biotech Bay
With Big Pharma Failing, Ackman And Novartis AG Try A New Blueprint For Drug Companies
April 23, 2014
·
1 min read
Biotech Bay
Latest Multiple Sclerosis Auto-Injector Developed With Ergonomic Focus, Novartis AG And Cambridge Consultants Reveal
April 10, 2014
·
1 min read
Biotech Bay
New Novartis AG Heart Drug Might Achieve Blockbuster Status
April 2, 2014
·
1 min read
Novartis AG Chief Reshapes Drugmaker For “Brutal” New World
March 20, 2014
·
1 min read
Biotech Bay
Shark Oil for HIV Shot Takes Cue From Hemingway’s Old Man, Novartis AG Reveals
June 27, 2012
·
1 min read
Policy
Will Novartis AG Sue Kanye West Over Theraflu?
April 9, 2012
·
1 min read
Biotech Bay
Novartis AG’s Joe Jimenez on Layoffs in Good Times
April 6, 2012
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
July 2, 2026
·
7 min read
Press Releases
Antares Therapeutics Enters Agreement with Novartis to Discover, Develop and Commercialize First-in-Class Cancer Therapies
June 24, 2026
·
2 min read
Press Releases
Novartis Canada and SP Quebec Celebrate 16 Years of Partnership Through Annual MS Tri-Challenge Fundraiser
June 24, 2026
·
4 min read
Press Releases
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
June 17, 2026
·
2 min read
Press Releases
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
June 12, 2026
·
11 min read
Press Releases
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
June 11, 2026
·
8 min read
Press Releases
Orionis Biosciences Announces Strategic Collaboration with Novartis to Discover and Develop Molecular Glue Medicines
June 10, 2026
·
2 min read
Press Releases
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
June 8, 2026
·
6 min read
Press Releases
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
June 4, 2026
·
11 min read
Press Releases
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
June 4, 2026
·
10 min read
